A tornado that tore through a Pfizer factory in North Carolina could exacerbate drug shortages. Records obtained by NPR show the plant made dozens of products, including painkillers and anesthetics.

After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.

The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign.

The arthritis drug Humira has been a blockbuster seller for more than two decades. Now some copycats could end Humira's reign.

Russia announced it is suspending participation in the Black Sea Grain Initiative, as a key bridge linking annexed Crimea to the Russian mainland was attacked again.

The Food and Drug Administration has approved the first over-the-counter birth control pill. The daily oral contraceptive, called Opill, will be available without a prescription.

Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year.

A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here's what really went down.

Strep throat is more prevalent this year, and amoxicillin manufacturers didn't make enough of the antibiotic to go around.

There's a nationwide shortage of the antibiotic amoxicillin. It is making it harder for doctors to treat strep throat.

Future access to the abortion drug mifepristone is called into question following competing rulings from federal judges in Texas and Washington State.

The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.

The FDA approved Narcan for sale without a prescription. The opioid overdose reversal drug would be available at pharmacies and convenience stores nationally, increasing access as opioid deaths climb.

Moderna is quadrupling the price of its COVID-19 vaccine when the U.S. government is no longer the exclusive buyer. Senators grilled the company's CEO on the hike and access for the uninsured.

Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.

The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.

Moderna said people without insurance will be able to get its COVID vaccine at no cost after the U.S. government bows out. But patients will have to use the company's cumbersome assistance program.

An insulin maker is cutting its prices. Eli Lilly, one of the three makers of insulin products in the United States, is also making other moves toward affordability for people with diabetes.

The U.S. Food and Drug Administration late last year got more leverage over pharmaceutical companies that received accelerated approvals for their drugs. How will the agency use its new powers?

A federal judge is set to rule in a case challenging the FDA's approval of an abortion pill decades ago. Siding with the anti-abortion group may have ripple effects on drug approvals as we know them.